Evidence map›Paper›PMID 41517519›Full record

ArticleJournal of clinical medicine2025

Evaluation of Autoimmune FVIII Inhibitor Using Clot Waveform Analysis in Emicizumab-Treated Patients.

Shigehisa Tamaki, Hideo Wada, Naoki Shinke, Junichiro Nishiki, Ryota Sasao, Atsushi Fujieda, Takeshi Matsumoto, Isao Tawara, Teruto Hashiguchi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shigehisa TamakiDepartment of Hematology, Japanese Red Cross Ise Hospital, 471-2 Hunae-Ichome, Ise 516-8512, Mie, Japan.
Hideo WadaDepartment of General Medicine, Mie Prefectural General Medical Center, 5450-132 Ohaza Hinaga, Yokkaichi 510-8561, Mie, Japan.ORCID 0000-0001-9021-8633
Naoki ShinkeDepartment of Hematology, Japanese Red Cross Ise Hospital, 471-2 Hunae-Ichome, Ise 516-8512, Mie, Japan.
Junichiro NishikiDepartment of Hematology, Japanese Red Cross Ise Hospital, 471-2 Hunae-Ichome, Ise 516-8512, Mie, Japan.
Ryota SasaoDepartment of Hematology, Japanese Red Cross Ise Hospital, 471-2 Hunae-Ichome, Ise 516-8512, Mie, Japan.
Atsushi FujiedaDepartment of Hematology, Japanese Red Cross Ise Hospital, 471-2 Hunae-Ichome, Ise 516-8512, Mie, Japan.ORCID 0009-0002-5592-3745
Takeshi MatsumotoDepartment of Transfusion Medicine and Cell Therapy, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe 350-8550, Saitama, Japan.
Isao TawaraDepartment of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.ORCID 0000-0002-5426-9422
Teruto HashiguchiDepartment of Laboratory and Vascular Medicine, Cardiovascular and Respiratory Disorders, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.

Funding

the Ministry of Health, Labor and Welfare of Japan 21FC1008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autoimmune factor VIII deficiencyclot waveform analysisemicizumabFVIIIinhibitor

Identifiers

PMID41517519
PMCPMC12787131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.